Comment on the American Association of Oral and Maxillofacial Surgeons statement on bisphosphonates.
Zahrowski
James J
JJ
D000284:Administration, Oral; D000539:Alveolar Process / Q000378:metabolism; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced*; D008657:Metabolic Clearance Rate; D010020:Osteonecrosis / Q000139:chemically induced*; D012953:Societies, Dental
D050071:Bone Density Conservation Agents; D004164:Diphosphonates